Forum of Clinical Oncology Healthcare access for cancer patients in the era of economic crisis . Results from the HOPE III study
نویسندگان
چکیده
Research evidence suggests that inequalities to healthcare access do exist in terms of cancer detection and treatment as well as in health outcomes amongst patients with cancer (1). Barriers such as living in rural area and have to travel a long distance to reach a health service, limited healthcare facilities and low availability of health services/medication treatment often prevent patients with cancer from seeking appropriate and effective care (2). Moreover, there are also factors at the level of patient with cancer related to limited access to effective care. People of low socioeconomic status, lower educational level and with limited social support face additional barriers in accessing healthcare services for the detection and treatment of cancer (3). The outbreak of economic crisis in Europe exacerbated the inequalities in health amongst and within European countries. In many cases, the policies implemented as a response to the recession, such as the decrease in the public health expenditure and the increase in the cost sharing in healthcare, have shifted the financial burden to households and led to differentiation of population’s health outcomes (4). Specifically, in Greece, the austerity plan implemented was targeted to achieve spending cuts of 1–5% of gross domestic product (GDP) in 2012 and additional cuts in the next two years. The public expenditure on health was estimated to do not exceed 6% of GDP whilst the unemployment rates continuing to raise (5, 6). Greece has the highest unemployment rate amongst the Organization for Economic Cooperation and Development (OECD) countries, found to be at 25.6% in 2015 (7). Although the economic situation in Greece is increasingly worsening and the financial crisis remains, the studies exploring the impact of the recession on health and healthcare access remain scarce. Forum of Clinical Oncology
منابع مشابه
Access to Care for Multiple Sclerosis in Times of Economic Crisis in Greece – the HOPE II Study
Background While there is currently no cure for multiple sclerosis (MS), treatment with biologic diseasemodifying drugs (bDMDs) can reduce the impact of the condition on the lives of patients. In Greece, the regulatory change in the distribution system of bDMDs, limited their administration through the designated pharmacies of the National Organization for Healthcare Services Provision (EOPYY) ...
متن کاملAxillary irradiation in breast cancer; does meticulous contouring make a difference?
Background: Due to the current trends towards replacing axillary dissection with radiotherapy, the need for more precise definition for different nodal stations becomes a must to ensure safe and adequate dose coverage. So, our study aimed to evaluate the coverage of axillary nodal volumes based on Project on Cancer of the Breast (PROCAB) guidelines, for cases previously treated with our standar...
متن کاملResponse to neoadjuvant chemotherapy in locally advanced gastric and gastroesophageal cancer: Phase II clinical trial
Background: Gastric cancer is an important health problem across the world. Chemotherapy in combination with local treatment is standard treatment for locally advanced gastroesophageal cancers. The purpose of this investigation was evaluation of response and tolerability to neoadjuvant EOX regimen in locoregionally advanced gastric cancer. Materials and Methods: patients with locoregionally adv...
متن کاملSocial Determinants of Equity in Access to Healthcare for Tuberculosis Patients in Republic of Macedonia – Results from a Case-Control Study
Background Health is a complex phenomenon and equity as a basic human right an integral part of constitutions in almost all countries in the world. In Republic of Macedonia (RM), Tuberculosis (TB) is clustered regionally and in certain ethnic groups. The main objective of this study was to analyze Social Determinants of Health (SDH) and equity in access to healthcare services for TB patients in...
متن کاملSurvival in Nonmetastatic Gastric Cancer Patients
Background & Aims: Gastric carcinoma is the second most frequent cancer worldwide. Adjuvant treatment of gastric cancer varies worldwide; many differences have been observed in their clinical and pathological features, and survival rate. The aim of this study was to determine clinical and pathological features, and survival rate in a group of patients in south-east of Iran. Methods: Patient rec...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2016